Back
Altimmune Vs. RH Industry Stock Comparison
Sell
32
ALT
Altimmune
Last Price:
$5.90
Seasonality Move:
-9.61%
Sell
35
RH
RH
Last Price:
$225.25
Seasonality Move:
17.71%
Sell
32
Altimmune (ALT)
is a Sell
Is Altimmune a Buy, Sell or Hold?
-
ALT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
RH (RH)
is a Sell
Is RH a Buy, Sell or Hold?
-
RH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.34 | Sell |
Relative Strength Index (14 RSI): | 47.33 | Sell |
Chaikin Money Flow: | 6842135 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.67 - 6.67) | Sell |
Bollinger Bands (100): | (6.22 - 8.3) | Sell |
RH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -44.02 | Sell |
Relative Strength Index (14 RSI): | 22.36 | Sell |
Chaikin Money Flow: | 703318 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (271.41 - 394.57) | Sell |
Bollinger Bands (100): | (316.4 - 417.74) | Sell |
ALT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.59 | Buy |
20-day SMA: | 6.04 | Sell |
50-day SMA: | 6.56 | Sell |
200-day SMA: | 6.99 | Sell |
8-day EMA: | 5.66 | Buy |
20-day EMA: | 5.98 | Sell |
50-day EMA: | 6.52 | Sell |
200-day EMA: | 7.05 | Sell |
RH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 254.79 | Sell |
20-day SMA: | 315.55 | Sell |
50-day SMA: | 375.12 | Sell |
200-day SMA: | 320.75 | Sell |
8-day EMA: | 254 | Sell |
20-day EMA: | 301.75 | Sell |
50-day EMA: | 346.39 | Sell |
200-day EMA: | 334.48 | Sell |
Altimmune Earnings Growth & ALT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.09 per share, an increase this year of $0.16 per share, and a decrease next year of $0.46 per share.
RH Earnings Growth & RH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.69 per share, a decrease next quarter of $0.78 per share, a decrease this year of $2.07 per share, and an increase next year of $7.32 per share.
Altimmune Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
RH Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |